share_log

艾美疫苗：2023年股東週年大會通告

AIM VACCINE: NOTICE OF 2023 ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 25 05:35
Summary by Moomoo AI
艾美疫苗股份有限公司將於2024年5月20日在上海舉行2023年股東週年大會，審議包括董事會報告、監事會報告、年報、經審計財務報表、利潤分配方案及財務決算案在內的多項普通決議案。此外，會議還將討論授權董事會批准2024年度財務預算，以及續聘安永會計師事務所為來年度核數師的議題。特別決議案包括一般性授權董事會發行新股份及購回H股的提案。股東可委派代表出席大會並投票，而股份過戶登記將於2024年5月14日至5月20日暫停，以確定有資格出席大會的股東名單。所有決議案的投票結果將於會後公布。
艾美疫苗股份有限公司將於2024年5月20日在上海舉行2023年股東週年大會，審議包括董事會報告、監事會報告、年報、經審計財務報表、利潤分配方案及財務決算案在內的多項普通決議案。此外，會議還將討論授權董事會批准2024年度財務預算，以及續聘安永會計師事務所為來年度核數師的議題。特別決議案包括一般性授權董事會發行新股份及購回H股的提案。股東可委派代表出席大會並投票，而股份過戶登記將於2024年5月14日至5月20日暫停，以確定有資格出席大會的股東名單。所有決議案的投票結果將於會後公布。
AMIE VACCINES CO., LTD. WILL HOLD ITS 2023 ANNUAL GENERAL MEETING IN SHANGHAI ON MAY 20, 2024 TO REVIEW A NUMBER OF GENERAL RESOLUTIONS INCLUDING BOARD REPORTS, BOARD OF SUPERVISORS REPORTS, ANNUAL REPORTS, AUDITED FINANCIAL STATEMENTS, PROFIT DISTRIBUTION SOLUTIONS AND FINANCIAL RESOLUTIONS. In addition, the meeting will discuss the issues of authorising the Board of Directors to approve the 2024 financial budget and the renewal of EY's auditor of the year. The Special Resolution includes a proposal to authorize the Board of Directors to issue new shares and to repurchase H shares. Shareholders may appoint representatives to attend the General Meeting and vote, and the registration of shares will be suspended from 14 May to 20 May 2024 to determine the list of shareholders eligible to attend the General Meeting. The voting results of all resolutions will be announced after the meeting.
AMIE VACCINES CO., LTD. WILL HOLD ITS 2023 ANNUAL GENERAL MEETING IN SHANGHAI ON MAY 20, 2024 TO REVIEW A NUMBER OF GENERAL RESOLUTIONS INCLUDING BOARD REPORTS, BOARD OF SUPERVISORS REPORTS, ANNUAL REPORTS, AUDITED FINANCIAL STATEMENTS, PROFIT DISTRIBUTION SOLUTIONS AND FINANCIAL RESOLUTIONS. In addition, the meeting will discuss the issues of authorising the Board of Directors to approve the 2024 financial budget and the renewal of EY's auditor of the year. The Special Resolution includes a proposal to authorize the Board of Directors to issue new shares and to repurchase H shares. Shareholders may appoint representatives to attend the General Meeting and vote, and the registration of shares will be suspended from 14 May to 20 May 2024 to determine the list of shareholders eligible to attend the General Meeting. The voting results of all resolutions will be announced after the meeting.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more